LPCN 1021

Lipocine Inc (NASDAQ: LPCN) is a nano-cap specialty pharmaceutical company whose lead product candidate is an oral testosterone replacement therapy called LPCN 1021. Shares of Lipocine were trading higher by more than 12 percent ahead of Monday's opening bell after the company announced the...